AstraZeneca planning offer for Amarin

Amarin Corporation, the Nasdaq-listed biotech company, is in line for a cash takeover offer from AstraZeneca. UK-listed AstraZeneca is attracted by Amarin’s FDA-approved Vascepa treatment for cardiovascular problems. Amarin could also be…